| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
5.94 0.17 (0.03%) |
02-19 16:00 |
|
Open: |
5.79 |
Pre close: |
5.77 |
Target:
|
7.60 
|
|
High: |
6.0003 |
Low: |
5.78 |
Resistance:
|
6.51
7.38
|
|
Volume: |
9,640 |
Market Cap: |
110M |
Support:
|
5.10
4.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.69
|
MACD |
MACD(12,26):
|
0.06  |
|
MA(20): |
6.22 |
Signal(12,26,9): |
0.19 |
|
MA(100): |
5.27 |
Stochastic Oscillator |
%K(14,3):
|
18.80 |
|
MA(250): |
6.82 |
%D(3): |
13.19 |
|
Average Volume(K) |
3-Month: |
1773
|
52-Week |
High:
|
10.57 |
|
10-Days: |
1600 |
Low: |
3.66 |
|
RSI |
RSI(14):
|
51.80 |
Change(%): |
-38.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.160 |
Return on Equity (ttm) |
-43.3 |
Shares Out. (M) |
18.56 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-38.4 |
Shares Float (M) |
18.39 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
55.80 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.910 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.86 |
P/S |
1837440000.00 |
|
Operating Margin |
-3573.95 |
Levered Free Cash Flow
(M) |
-14.49 |
P/CF |
-4.43 |
|
|
|
|
|
|
